Medtronic today announced it appointed former Amazon executive Ken Washington as chief technology and innovation officer. In this newly created role, Washington will leverage his extensive experience leading technology development and execution across industries, including robotics, consumer products, automotive and space. He will also become a member of the Medtronic Executive Committee. “This new leadership […]
Medtronic
A veteran Medtronic executive takes a new role at Baxter
Medtronic Cardiovascular Diagnostics and Services President Julie Brewer has left for a new position at Baxter. Brewer announced on LinkedIn near the end of last week that she has joined Baxter as President of the Patient Support Systems, Global Surgical Solutions and Care Communications team. “Baxter is a great company with a wonderful purpose of […]
Medtronic faces a wait-and-see attitude from analysts
Medtronic stock continues to decline today — a day after it underwhelmed The Street with its growth projection for its new fiscal year. MDT shares were down more than 2% to $81.58 apiece by midday today — a day after the stock fell another 2% in value. Meanwhile, MassDevice’s MedTech 100 Index — as well […]
Analysts still high on Insulet despite Medtronic’s EOFlow buy, stock market reaction
Despite a negative reaction from investors following a major buy in the insulin delivery space, analysts still back Insulet stock to perform. Shares of PODD fell throughout today after Medtronic (NYSE:MDT) announced a $738 million acquisition of EOFlow. Korea-based EOFlow develops the EOPatch, a tubless, wearable and fully disposable insulin delivery device. Insulet represents a […]
The top cardiac care innovation news at Heart Rhythm 2023
The future of cardiac care was on display at the Heart Rhythm Society’s 2023 annual meeting. Medical device companies showcased groundbreaking technologies at Heart Rhythm 2023, May 19-21 in New Orleans. The innovations presented during the event offer new avenues for diagnosis, treatment, and monitoring of cardiovascular conditions, providing hope for patients worldwide. Boston Scientific, […]
Medtronic stock down as growth projections underwhelm
Medtronic today reported fourth-quarter results that beat the consensus forecast on Wall Street amid accelerating revenue growth. The world’s largest medical device company also announced an acquisition, planning to pay roughly $738 million for South Korea–based EOFlow and its EOFlow insulin delivery patch that a user can control using their smartphone. However, its forecast for […]
Medtronic to acquire wearable insulin patch maker EOFlow for $738M
Medtronic (NYSE:MDT) announced today that it entered into a set of agreements to acquire insulin delivery technology developer EOFlow. Seongnam, South Korea-based EOFlow develops the EOPatch — a tubeless, wearable and fully disposable insulin delivery device. EOFlow already launched its EOPatch insulin delivery system in Korea and Europe. The company submitted the insulin delivery device […]
Medtronic reports positive Harmony transcatheter pulmonary valve data
Medtronic (NYSE:MDT) announced positive two-year results for a study of its Harmony transcatheter pulmonary valve (TPV) system. Harmony treats severe pulmonary regurgitation (PR) in the native or surgically repaired right ventricular outflow tract (RVOT). The Medtronic analysis demonstrates strong clinical and hemodynamic outcomes for patients with a congenital heart defect of the RVOT. The current […]
Study supports extravascular ICD from Medtronic
Medtronic (NYSE:MDT) announced positive long-term follow-up results for its investigational implantable cardioverter defibrillator (ICD). The medtech giant designed its extravascular (EV) ICD system to treat dangerously fast heart rhythms that can lead to sudden cardiac arrest. Medtronic’s EV ICD pivotal study followed patients through an average of 17.1 months. The company presented data as late-breaking […]
Medtronic reports positive study results for PulseSelect pulsed-field ablation system
Medtronic (NYSE:MDT) today announced positive findings from a secondary analysis of the PULSED AF study for its pulsed-field ablation technology. The analysis demonstrated positive results for the PulseSelect system, including atrial arrhythmia (AA) burden reduction. This correlated to both improved quality of life and decreased healthcare utilization. Medtronic said in a news release that 87% […]
Medtronic and Johnson & Johnson reportedly consider Shockwave acquisition
Medtronic (NYSE:MDT) and Johnson & Johnson (NYSE:JNJ) are interested in acquiring Shockwave Medical (Nasdaq:SWAV), according to a StreetInsider.com report citing an unnamed source. The financial news website did not say how the source knows the information or why they are not being identified by name. “We don’t comment on rumors or speculation,” Medtronic spokesperson Erika […]
